F
Francesco Cipollone
Researcher at University of Chieti-Pescara
Publications - 228
Citations - 9635
Francesco Cipollone is an academic researcher from University of Chieti-Pescara. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 49, co-authored 195 publications receiving 8335 citations. Previous affiliations of Francesco Cipollone include University of Rome Tor Vergata & University of Messina.
Papers
More filters
Journal ArticleDOI
Cox-2 polymorphisms and cardiovascular disease: elucidating the hidden side of the disease.
TL;DR: It is now evident that conventional risk factors for myocardial infarcion, such as hypertension, diabetes, dyslipidemia and obesity all esult from the interaction between multiple susceptibility loci ith behaviour and the environment.
Journal ArticleDOI
Gastrointestinal manifestations of SARS-CoV-2 infection in an Italian population of hospitalized patients
Angelo Milano,Konstantinos Efthymakis,Damiano D'Ardes,Marco Tana,Elena Mazzotta,Giulia De Febis,Francesco Laterza,Pierluigi Tarquini,Enrico Marini,Ettore Porreca,Francesco Cipollone,Matteo Neri +11 more
TL;DR: This study on an Italian population during the outbreak of the COVID-19 pandemic shows that GI symptoms are part of the spectrum of the SARS-CoV-2 infection and could be the only manifestations at disease onset.
Journal ArticleDOI
Differential TBXA2 receptor transcript stability is dependent on the C924T polymorphism.
Vincenzo De Iuliis,Sebastiano Ursi,A Pennelli,Marika Caruso,Angela Nunziata,Antonio Marino,Vincenzo Flati,Francesco Cipollone,Maria Adele Giamberardino,Gianfranco Vitullo,Elena Toniato,Pio Conti,Stefano Martinotti +12 more
TL;DR: The instability of the TBXA2R transcript and the lack of effect on platelet aggregation might suggest a protective role for the TBXM2R TT genotype against atherothrombosis and its complications in high-risk aspirin-treated patients.
Journal ArticleDOI
Angiotensin II Blockade and Total Cardiovascular Risk
TL;DR: ACE inhibitors and ARBs are very important drugs in the modern management of the total cardiovascular risk in hypertensive patients because of the existence of blood pressure-independent effects.
Journal ArticleDOI
Flow-mediated vasodilation: improving specificity for endothelial function evaluation.
TL;DR: Under persistent pathological conditions such as hypertension, endothelial activity is greatly impaired, and endothelium undergoes rapid structural and functional changes that finally result in impaired vasorelaxation, oxidative stress and increased adhesiveness for circulating leukocytes (mainly monocytes and T-lymphocytes).